SEC Form 10-Q Summary
Filing context: The supplied filing identifies the registrant as Bioflamex Corporation, not Cann American Corp. It covers the three months ended May 31, 2012; the request metadata states “2011 Q1,” which does not match the filing period. The company was a development-stage enterprise pursuing environmentally friendly fire-extinguishing products and, subsequent to the quarter, a telecommunications business combination with Terra Asset Management.
Financial position and results
| Metric | Three months ended May 31, 2012 | Comparable 2011 period |
|---|---|---|
| Revenue | $0 | $0 |
| Operating expenses | $209,598 | $81,631 |
| Net loss | $364,242 | $83,584 |
| Operating cash flow | $(231,881) | $(42,313) |
| Investing cash flow | $0 | $0 |
| Financing cash flow | $242,524 | $50,000 |
| Ending cash | $10,834 | $7,746 |
- At May 31, 2012, total assets were $1.21 million, including $1.191 million of non-amortizable intellectual property, while current liabilities were $215,211.
- Working capital was negative $197,064. Total liabilities consisted of current liabilities; convertible notes payable were $158,970.
- Stockholders’ equity was $993,936, compared with $904,423 at February 29, 2012. Shares outstanding were 150,550,121 at May 31, 2012.
- No meaningful margin analysis is available because the company had no revenue. Basic and diluted loss per share was reported as approximately $0.00.
Material changes versus the prior comparable period
- Operating expenses increased approximately 157%, primarily from $120,000 of related-party executive compensation, $61,516 of consulting fees, and $150,133 of share-based compensation recognized through operating or financing-related activity.
- Net loss increased approximately 336% to $364,242, driven by higher operating expenses and $151,872 of finance costs associated with convertible debt conversions and financing.
- Operating cash usage increased to $231,881 from $42,313. Financing inflows increased to $242,524, principally from convertible debenture proceeds.
- The company issued substantial equity for services and debt conversions, including 24 million shares to officers for services, 18.8 million shares issued upon conversion of Magna obligations, and shares issued in connection with the Dutchess financing arrangement.
- Previously reported financial statements were restated for accrued expenses and related errors. The filing’s prior-period figures are therefore not fully comparable to amounts originally reported.
Outlook, risks, and unusual items
- Management stated that the company had not generated revenue since inception, expected continued substantial losses, and did not expect near-term profitability.
- The filing contains substantial doubt regarding the company’s ability to continue as a going concern. Future operations depend on additional debt or equity financing, product sales, and expense control.
- Management estimated that a cash injection of approximately $2.0 million was needed to begin operations, conduct marketing, manufacture and deliver products, and generate revenue.
- A Dutchess Opportunity Fund agreement contemplated purchases of up to $10 million of common stock over 36 months, subject to conditions including an effective resale registration statement. The facility was not a guaranteed source of financing.
- Product plans included production and market penetration of Bioflamex aerosol extinguishers, regulatory certifications, distribution agreements, and continued patent development. Key supplier and production agreements were described as drafted or otherwise in development, creating execution risk.
- The Sentinel forest-fire detection and suppression project was delayed following the death of a key development partner.
- Disclosure controls and procedures were deemed ineffective because of inadequate segregation of duties, risk assessment, and written accounting and reporting policies. Management had not remediated these material weaknesses during the quarter.
- Subsequent events included a $37,500, 22% convertible note issued to Asher Enterprise on June 11, 2012, and a July 2012 merger involving Terra Asset Management. The filing describes Terra as the accounting survivor in the merger-related disclosures.
Investor verification points
- Confirm the correct issuer and reporting period, because the request names Cann American Corp. and 2011 Q1 while the filing names Bioflamex Corporation and covers May 31, 2012.
- Assess the valuation, recoverability, and related-party origin of the $1.191 million intellectual-property asset.
- Review the terms, conversion features, dilution potential, and maturity dates of the convertible notes and the Dutchess equity facility.
- Verify the extent of subsequent dilution from shares issued for executive compensation, consulting services, financing fees, and debt conversions.
- Evaluate liquidity and going-concern risk in light of $10,834 of cash, negative working capital, no revenue, and reliance on external financing.
- Review the restatement for previously unrecorded expenses and the identified material weaknesses in internal controls.
- Confirm the accounting and business consequences of the subsequent Terra Asset Management merger.